Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
22-Aug-2025 | 481.8 | 486 | 476.15 | 480.05 | 5,167 | 5,63,96,841.65 | 58,607 |
25-Aug-2025 | 491.95 | 491.95 | 470.75 | 478.35 | 26,543 | 56,17,11,238 | 9,39,760 |
26-Aug-2025 | 478.35 | 481.5 | 469.6 | 477.1 | 15,922 | 20,36,20,705.1 | 2,84,263 |
28-Aug-2025 | 481 | 481 | 464.15 | 467.9 | 13,850 | 21,43,69,125.3 | 3,29,945 |
29-Aug-2025 | 467.9 | 469.55 | 452.2 | 454.25 | 14,716 | 10,82,69,265.5 | 1,37,401 |
01-Sep-2025 | 456 | 470.85 | 456 | 466.8 | 9,034 | 11,35,44,155.3 | 1,54,043 |
02-Sep-2025 | 468 | 477 | 466.05 | 472.7 | 3,438 | 3,63,91,284.65 | 38,814 |
03-Sep-2025 | 472.7 | 479 | 467.7 | 474.05 | 4,885 | 3,68,11,094.5 | 36,556 |
04-Sep-2025 | 477 | 482.05 | 461.1 | 465.65 | 11,249 | 5,89,82,507.2 | 74,821 |
05-Sep-2025 | 467.45 | 474.45 | 459.1 | 460.2 | 8,081 | 8,77,47,804.2 | 1,20,233 |
08-Sep-2025 | 469.2 | 469.65 | 455 | 466.2 | 8,932 | 12,19,59,936.5 | 1,59,445 |
09-Sep-2025 | 466.2 | 469.4 | 461.1 | 462.25 | 9,057 | 8,21,20,276.05 | 1,21,750 |
10-Sep-2025 | 463 | 473.8 | 463 | 468.7 | 8,095 | 6,47,33,441.1 | 68,875 |
11-Sep-2025 | 469 | 472.95 | 455 | 459.65 | 11,714 | 15,03,44,245.4 | 2,05,231 |
12-Sep-2025 | 461 | 469.4 | 458.75 | 462 | 9,480 | 16,02,04,890.9 | 2,14,756 |
15-Sep-2025 | 464.25 | 474.5 | 459.05 | 470.35 | 12,561 | 13,51,14,513.2 | 1,65,569 |
16-Sep-2025 | 470.9 | 478.5 | 465.95 | 475 | 6,720 | 9,09,45,054.95 | 87,723 |
17-Sep-2025 | 478 | 478 | 470 | 471.4 | 4,118 | 4,41,69,266.35 | 45,945 |
18-Sep-2025 | 473.9 | 476.4 | 469.5 | 474.95 | 3,255 | 4,07,76,605.45 | 43,665 |
19-Sep-2025 | 477 | 479.6 | 472.15 | 476.5 | 3,299 | 4,03,60,454 | 44,246 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
